Framework for Building a Digital Supply Chain for Chemical Procurement Risk Management
If the raw materials stop, the factory stops. A procurement resilience strategy that visualizes dependence on specific countries and regulatory risks digitally.
We provide a practical framework for visualizing procurement risks and building a digital supply chain for chemical manufacturers. In response to the unique triple risks of dependence on specific countries, strengthened chemical regulations, and difficulty in finding alternatives, we achieve stable procurement through alternative source evaluation and digital anomaly detection from normal times. We offer a free procurement risk diagnosis, so please feel free to contact us.
basic information
【Specifications】 - Four-layer structure for digital procurement management of chemicals (data collection, linking raw materials to products, risk detection and alternative planning, management procurement dashboard) - Three-step execution roadmap for procurement risk management - Comparison framework between traditional procurement management and the desired future state - Self-diagnosis check for procurement risk in chemicals - Free procurement risk diagnosis provided
Price range
Delivery Time
Applications/Examples of results
【Applications and Examples of Achievements】 - Quantification of supply concentration risks for chemical raw materials and identification of priority response materials - Redesign of procurement strategies considering geopolitics, chemical regulations, and disasters - Evaluation of alternatives for critical raw materials and promotion of expedited customer approvals - Digital real-time understanding of the operational status, inventory, and logistics of business partners - Centralized management of substances, including compliance with REACH and economic security promotion laws - Development of a management dashboard to simulate production impacts during raw material shortages
catalog（1）
Download All Catalogs
Recommended products
Distributors
Accenture transforms change into power, providing 360-degree value to customers, employees, shareholders, partner companies, and society. We support Bristol Myers Squibb by leveraging generative AI and automation to accelerate clinical trials and streamline drug development. We consolidate our full capabilities as a reinvention service to solve the most challenging problems. We guide enterprise transformation to be executed on a larger scale and with greater impact.